Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_assertion type Assertion NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_head.
- NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_assertion description "[We investigated the effect of single-nucleotide polymorphisms (SNPs) spanning 10 methotrexate (MTX) pathway genes, namely AMPD1, ATIC, DHFR, FPGS, GGH, ITPA, MTHFD1, SHMT1, SLC19A1 (RFC) and TYMS on the outcome of MTX treatment in a UK rheumatoid arthritis (RA) patient cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_provenance.
- NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_assertion evidence source_evidence_literature NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_provenance.
- NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_assertion SIO_000772 22450926 NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_provenance.
- NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_assertion wasDerivedFrom befree-20140225 NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_provenance.
- NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_assertion wasGeneratedBy ECO_0000203 NP466501.RA_bYE9Q970Xn_xHe-CiOaMn9Hxid_BCLPyc16XQ67Y_Y130_provenance.